Coherent, Inc. (COHR) Stock Analysis
Is COHR a good investment?
Coherent, Inc. (COHR) has a Plutrex AI rating of 81.0/100 as of August 20, 2026, indicating a Strong Buy consensus. The stock is not classified as halal-compliant. Key strength: Forward EPS growth of 48.9% (next year AND 5-year) is exactly 2x the industry average of 24.4% — validated by historical YoY EPS growth of 55.6% already exceeding forward projections, making these estimates credible rather than aspirational. PEG of 0.42 vs. industry average of 1.16 means COHR's growth is priced at a 63.8% discount to peers — the most compelling relative value signal in the analysis.. Main concern: Negative FCF of -$649.98M is WORSENED significantly from -$197.6M in the prior report — this is the most critical financial risk. The company is consuming cash at an accelerating rate, and while the $2.0B cash position provides ~3 years of runway, FCF must improve as AI revenues scale or the balance sheet will become strained. The headline 'Margin improvement has been soft relative to explosive top-line revenue growth' confirms this concern is real and not yet resolved..
Investment Summary
COHR is a high-conviction Buy at current levels ($287.47), representing a materially better entry point than my prior report's $349 midpoint — a 19.2% price decline while the analyst consensus target actually rose from $396.17 to $416.27 (+5.1%). The investment thesis is driven by exceptional growth (48.9% forward EPS growth vs. industry average of 24.4% — exactly 2x the sector), a PEG ratio of 0.42 (vs. industry average of 1.16, a 63.8% discount), and a 44.8% upside to the analyst consensus target of $416.27. The P/E of 69.9x appears elevated in isolation but compresses rapidly: at 48.9% annual EPS growth, the forward P/E drops to ~46.9x in year 1 and ~31.5x in year 2 without any price appreciation. The primary concern is negative FCF of -$649.98M (worsened from -$197.6M in the prior report), which is the single most important risk to monitor. However, this is partially offset by a $2B cash position (~3 years of runway) and the expectation that FCF improves as AI-driven revenues scale past fixed cost thresholds. The 19.2% stock decline since my prior report is not justified by fundamentals — it appears to be a post-earnings technical reaction — and creates a significantly more attractive entry point. COHR is a critical AI infrastructure supplier (transceiver components, silicon carbide substrates) with industry-leading margins (operating margin 11.83% vs. industry average 3.97%) and the most compelling growth-to-valuation ratio in its peer group.
Key Strengths
- Forward EPS growth of 48.9% (next year AND 5-year) is exactly 2x the industry average of 24.4% — validated by historical YoY EPS growth of 55.6% already exceeding forward projections, making these estimates credible rather than aspirational. PEG of 0.42 vs. industry average of 1.16 means COHR's growth is priced at a 63.8% discount to peers — the most compelling relative value signal in the analysis.
- AI infrastructure positioning creates a structural demand tailwind: COHR supplies transceivers and silicon carbide substrates critical for next-generation AI chips and data center buildout. Revenue growth of 33.7% (vs. industry 25.5%) and the headline 'AI Demand Is Outrunning Its Factories' confirm demand is real and accelerating — the constraint is supply capacity, not customer appetite.
- 19.2% stock price decline since prior report ($355.64 → $287.47) while analyst consensus target ROSE from $396.17 to $416.27 (+5.1%) creates a dramatically improved risk/reward: upside to analyst target expanded from 11.4% to 44.8%. Operating margin of 11.83% vs. industry average of 3.97% and net margin of 10.82% vs. industry average of -14.89% confirm COHR is a profitable leader in a sector dominated by money-losing peers.
Key Concerns
- Negative FCF of -$649.98M is WORSENED significantly from -$197.6M in the prior report — this is the most critical financial risk. The company is consuming cash at an accelerating rate, and while the $2.0B cash position provides ~3 years of runway, FCF must improve as AI revenues scale or the balance sheet will become strained. The headline 'Margin improvement has been soft relative to explosive top-line revenue growth' confirms this concern is real and not yet resolved.
- Technical momentum is weak: the stock has fallen 19.2% since the prior report despite a record FY26 and strong guidance. The headline 'Coherent: Why A Post-Earnings Sell-Off Looks About Right' suggests some analysts view the selloff as justified, and 'Coherent After a Record FY26: Is the Stock a Buy After Q4 Earnings?' reflects ongoing investor uncertainty. Near-term selling pressure may persist before the stock stabilizes, and the prior stop-loss of $318 has already been breached — requiring a reset of technical levels.
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
COHR's fundamentals present a classic high-growth technology profile with clear strengths and one critical weakness. GROWTH (dominant factor): Forward EPS growth of 48.9% (next year and 5-year) vs. industry average of 24.4%/26.8% — COHR grows earnings at 2x the sector rate. Historical YoY EPS growth of 55.6% validates forward projections as achievable. Revenue growth of 33.7% vs. industry average of 25.5% confirms top-line momentum. VALUATION: PEG of 0.42 vs. industry average of 1.16 — trading at 63.8% discount to peers on growth-adjusted basis. P/E of 69.9x vs. industry average of 1,444.9x (distorted by loss-makers) — COHR is among the most reasonably valued profitable companies in the sector. Analyst consensus target of $416.27 implies 44.8% upside. PROFITABILITY: Gross margin 38.4% (vs. industry 33.7%), operating margin 11.83% (vs. industry 3.97% — a 198% premium), net margin 10.82% (vs. industry average of -14.89% — categorical advantage as COHR is profitable while average peer loses money). ROE of 8.5% is the one weak spot, below industry average of 10.6%, reflecting the gap between P/B of 5.16x and current earnings generation — but this gap closes rapidly at 48.9% EPS growth. FINANCIAL HEALTH (critical concern): Negative FCF of -$649.98M (worsened significantly from -$197.6M prior report) is the primary risk. Cash of $2.0B provides ~3 years runway. Debt-to-equity of 0.32 vs. industry average of 0.497 — conservative leverage is a genuine strength.
News Sentiment
Coherent Corp. is navigating a pivotal moment: the company just delivered a record fiscal year 2026, yet its stock has tumbled nearly 20% — leaving investors wondering whether the selloff is an opportunity or a warning sign. The answer, according to the data, leans strongly toward opportunity. The headline 'Coherent: Why A Post-Earnings Sell-Off Looks About Right' captured the bearish narrative — some analysts argued the stock's premium valuation left little room for error even after strong results. But the companion piece 'Coherent After a Record FY26: Is the Stock a Buy After Q4 Earnings?' frames the other side: a company delivering record revenues in the AI infrastructure boom, now trading at a 44.8% discount to analyst consensus targets. The real story is in the supply chain. 'Coherent: AI Demand Is Outrunning Its Factories' is perhaps the most important headline — it tells you demand isn't the problem. Hyperscalers are ordering faster than Coherent can build. The company is also expanding its technology footprint: 'Coherent Begins Customer Sampling of 300mm High Thermal Conductivity Silicon Carbide' signals a move into next-generation semiconductor substrates critical for AI chips. The catch? Margins haven't kept pace with revenue growth, and free cash flow remains deeply negative. For patient investors, the setup looks compelling: a profitable AI infrastructure supplier growing earnings at twice the industry average, now trading at a significant discount after a post-earnings overreaction.
Risk Assessment
PRIMARY RISK: Negative FCF of -$649.98M (worsened from -$197.6M) is the most critical execution risk. If FCF does not improve materially within 2-3 quarters as AI revenues scale, the $2.0B cash reserve will deplete faster than expected, potentially forcing dilutive capital raises. Monitor FCF quarterly — any further deterioration below -$700M would be a sell signal. SECONDARY RISK: Multiple compression risk at P/E of 69.9x. If the 48.9% EPS growth trajectory disappoints even modestly (e.g., drops to 30-35%), the P/E could compress sharply, overwhelming earnings growth and driving the stock lower. The headline 'Coherent: Why A Post-Earnings Sell-Off Looks About Right' suggests some market participants already question the growth sustainability. TERTIARY RISK: AI infrastructure spending could slow if hyperscaler capex cycles turn, directly impacting COHR's transceiver and substrate demand. MITIGATION: Stop-loss at $255 (~10% below entry midpoint of $283.50) is set below key psychological support at $260 and accounts for a scenario where FCF concerns escalate or AI demand disappoints. Position size of 3.5% reflects high conviction but acknowledges the FCF risk. The $2.0B cash position and 0.32 debt-to-equity provide meaningful downside protection against a liquidity crisis.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is COHR a halal stock?
No, Coherent, Inc. (COHR) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for COHR?
Coherent, Inc. (COHR) has a Plutrex AI rating of 81.0/100 with a Strong Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is COHR a good investment?
According to Plutrex AI, COHR has a Strong Buy rating (81.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in COHR?
US stocks like COHR can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in COHR?
Plutrex AI identifies the main risks for COHR by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.